Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study

M Filippi1, G J Barker, M A Horsfield

  • 1Institute of Neurology, Queen Square, London, UK.

Journal of Neurology
|February 1, 1994
PubMed
Summary

Quantitative MRI reveals differences in chronic brain lesions between benign and secondary progressive multiple sclerosis (MS). Small lesions in benign MS show higher T2 values, while secondary progressive MS may have greater axonal loss in larger lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B.

The Journal of infectious diseases·2025
Same author

Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial.

Journal of viral hepatitis·2025
Same author

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B.

Alimentary pharmacology & therapeutics·2025
Same author

New insights into the effects of ethylene on ABA catabolism, sweetening and dormancy in stored potato tubers.

Postharvest biology and technology·2021
Same author

Direct Measurement of Single-Molecule Ligand-Receptor Interactions.

The journal of physical chemistry. B·2020
Same author

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2019

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease characterized by demyelination and axonal damage.
  • Understanding the mechanisms of disability progression in MS is crucial for effective treatment strategies.
  • Quantitative magnetic resonance imaging (MRI) offers insights into lesion characteristics and their relationship to disease evolution.

Purpose of the Study:

  • To compare T2 values and decay characteristics of chronic brain lesions in benign MS versus secondary progressive MS.
  • To assess T2 values of normal-appearing white matter (NAWM) in both MS subtypes.
  • To evaluate brain lesion volumes and their correlation with disability development in MS.

Main Methods:

  • Quantitative MRI techniques were employed to measure T2 values and lesion volumes.

Related Experiment Videos

  • A cohort of 11 patients with clinically definite MS (5 benign, 6 secondary progressive) was studied.
  • Fifty-two chronic lesions were identified and analyzed, alongside NAWM, using established MRI protocols.
  • Main Results:

    • Small lesions exhibited higher mean T2 values in benign MS, potentially due to partial volume effects.
    • Biexponential T2 relaxation, indicative of axonal loss, was observed more frequently in large lesions of secondary progressive MS patients.
    • While not statistically significant, secondary progressive MS patients showed a trend towards higher total and infratentorial lesion loads.

    Conclusions:

    • Preliminary findings suggest that lesion characteristics, including size, location, and pathological nature (e.g., axonal loss), may influence disease progression patterns in MS.
    • Quantitative MRI parameters like T2 relaxation times can potentially differentiate between MS subtypes and predict disability.
    • Further research is warranted to establish the definitive role of these MRI metrics in understanding MS pathogenesis and evolution.